chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: She said she is having problem with, her face feels like numb and all kind of problems; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 01), for Covid-19 Immunization. The following information was reported: HYPOAESTHESIA (non-serious), outcome "unknown", described as "She said she is having problem with, her face feels like numb and all kind of problems". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Nausea, Vomiting
Clinical narrative: felt jacked up which was bad/felt like she was a mess; dizzy; nausea; was throwing up; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious) with onset 2021, outcome "not recovered", described as "felt jacked up which was bad/felt like she was a mess"; DIZZINESS (non-serious) with onset 2021, outcome "recovered" (2021), described as "dizzy"; NAUSEA (non-serious) with onset 2021, outcome "not recovered", described as "nausea"; VOMITING (non-serious) with onset 2021, outcome "not recovered", described as "was throwing up".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dyspepsia, Fatigue, Headache, Nausea
Clinical narrative: Headache; Nausea; Fatigue; I don't have any appetite; Indigestion; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 57 year-old female patient received bnt162b2 (BNT162B2) (Lot number: EW0172) at the age of 57 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Headache"; NAUSEA (non-serious), outcome "unknown", described as "Nausea"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue"; DECREASED APPETITE (non-serious), outcome "unknown", described as "I don't have any appetite"; DYSPEPSIA (non-serious), outcome "unknown", described as "Indigestion". Therapeutic measures were taken as a result of headache, nausea, fatigue, decreased appetite, dyspepsia.  Additional information: Treatment: Nurse stated, "Ibuprofen. When I had indigestion so I took Protonix. I had Indigestion also last night. Today, I have the nausea and the headache. The headache is the worst.   No follow-up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Nail growth abnormal, Parosmia
Clinical narrative: One- Two weeks after 1st vaccine Nail Growth and increased Strength/ Thickness; Increased sense of smell; Metallic taste in mouth; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date Aug2021 (Lot number: FA7484) at the age of 61 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "chronic fatigue immune syndrome CFIDS", start date: 1992 (unspecified if ongoing), notes: Chronic fatigue immune syndrome CFIDS diagnosed in 1992; "Latex allergy" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE SODIUM. Past drug history included: Polyethylene, reaction(s): "Allergies: Polyethylene"; Chlorhexidine, reaction(s): "Allergies: Chlorhexidine"; Dermabond, reaction(s): "Allergies: Dermabond"; Erythromycin, reaction(s): "Allergies: Erythromycin". Vaccination history included: Prevnar 13 vaccine, for Immunization, reaction(s): "Allergies: Prevnar 13 Vaccine". The following information was reported: NAIL GROWTH ABNORMAL (non-serious) with onset 05Aug2021, outcome "not recovered", described as "One- Two weeks after 1st vaccine Nail Growth and increased Strength/ Thickness"; PAROSMIA (non-serious) with onset 05Aug2021, outcome "not recovered", described as "Increased sense of smell"; DYSGEUSIA (non-serious) with onset 05Aug2021, outcome "not recovered", described as "Metallic taste in mouth". It was unknown if therapeutic measures were taken as a result of nail growth abnormal, parosmia, dysgeusia.  Additional Information: If other vaccine in four weeks: No. The patient was not diagnosed with COVID prior to vaccination. The patient has not tested for COVID post vaccination. Facility type vaccine: Pharmacy or Drug Store  No follow-up attempts are possible. No further information is expected.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Parosmia
Clinical narrative: smelling something that is not there/having a funny thing in her nose called phantosmia; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 81 year-old female patient received bnt162b2 (BNT162B2), administration date 28Feb2021 (Lot number: EN6205, Expiration Date: 30Jun2021) at the age of 80 years as dose 2, single and administered in arm left, administration date 07Feb2021 (Lot number: EL9264, Expiration Date: 31May2021) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Blockage in legs" (ongoing); "thyroid" (unspecified if ongoing); "esophagus" (ongoing). Concomitant medication(s) included: OMEPRAZOLE taken for oesophageal disorder (ongoing); ATORVASTATIN CALCIUM taken for limb discomfort (ongoing); BAYER CHILDREN'S ASPIRIN; NORVASC (ongoing). The following information was reported: PAROSMIA (non-serious) with onset Aug2021, outcome "not recovered", described as "smelling something that is not there/having a funny thing in her nose called phantosmia". Therapeutic measures were not taken as a result of parosmia.  Additional Information: She is calling about Pfizer covid shot. She does not think she has ever had covid. Two days ago she started having a funny thing in her nose called phantosmia, it is smelling something that is not there. It comes and goes. She was trying to read something that a doctor put into the oxford press, an article about the effects after the covid shot. Is there such a thing as phantosmia.  She called her primary's office and was told they never heard of it. States she might have got a breakthrough and thinks she may spread it if it is in her.  States she is having a time this morning when looking at the aspirin bottle. She takes a thyroid medication every morning and does not have it handy to provide the name, has been taking for a couple of years. She requested to be transferred for her question. States it may be nothing and wants to know if she is carrying covid and does not want to give it to anyone. She does not feel sick. She has this strange thing in her nose and does not know what it is. She does not know if she needs another test. She thinks the phantosmia started Monday or Tuesday, thinks it started Monday.  Treatment has been declines. She takes vitamins. States she is having a time this morning when looking at the aspirin bottle. She takes a thyroid medication every morning and does not have it handy to provide the name, has been taking for a couple of years. States she is having a time this morning when looking at the aspirin bottle. She takes a thyroid medication every morning and does not have it handy to provide the name, has been taking for a couple of years. She could not locate the strength on the Bayer Aspirin bottle. States everything is so small. There is so much written and did not see the strength at first, she was looking for printing and then was able to locate strength of 81mg.  No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Drug abuse, Drug screen positive
Clinical narrative: tested positive for methamphetamine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the parent.  A 32 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 11Aug2021 (Lot number: FA7485, Expiration Date: 01Sep2021) at the age of 32 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "spider bite" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "Depression" (unspecified if ongoing). Concomitant medication(s) included: BENADRYL taken for pruritus, start date: 12Aug2021 (ongoing); REXULTI taken for depression, start date: 12Aug2021; WELLBUTRIN, start date: 12Aug2021; SULFAMETHOXAZOLE, start date: 12Aug2021; BUSPIRONE taken for anxiety, panic attack, start date: 12Aug2021; TYLENOL taken for pain, start date: 12Aug2021. Past drug history included: Methamphetamines for Drug addict, notes: tested positive for Methamphetamines. The following information was reported: DRUG SCREEN POSITIVE (non-serious) with onset 12Aug2021, outcome "unknown", described as "tested positive for methamphetamine". The event "tested positive for methamphetamine" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient was received 1st dose of the Pfizer COVID 19 vaccine and is also taking Bactrim and Benadryl for a spider bite; states this morning the patient went and was drug tested and tested positive for Methamphetamines and reporter is inquiring if this is from the Pfizer COVID vaccine. The patient has had the spider bite for about a week. States she takes Benadryl for itching and just got it as over the counter for the spider bite, takes Rexulti 3mg once per day by mouth for depression, takes Wellbutrin but does not have the bottle of Wellbutrin for the dosage or instructions, clarifies she takes the generic of Bactrim which is Sulfamethoxazole-TMPDS one by mouth twice per day but does not see the dosage anywhere on the orange pharmacy bottle; states for the Sulfamethoxazole-TMPDS the orange pharmacy bottle has the Rx number but no lot, expiry date or NDC. States the patient took two Tylenol 500mg by mouth today; states the patient takes as a mood stabilizer Buspirone HCP two tablets three times per day as needed for anxiety or panic attacks and all of these medications were ones that they prescribed for her to help her with her mental health and with withdrawal from drugs. Reporter confirms that all of these medications were started by the patient this morning.   No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in his left arm began after he received the 1st shot; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 51 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Mar2021 (Lot number: ER8732) at the age of 51 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported.  The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "not recovered", described as "pain in his left arm began after he received the 1st shot".  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: numbness in toes/ 3 digits on one foot were numb; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 79 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose), for COVID-19 immunization. The following information was reported: HYPOAESTHESIA (non-serious), outcome "recovered", described as "numbness in toes/ 3 digits on one foot were numb".  Additional information: Extended family member reported experiencing numbness in toes following 2 dose of COVID 19 vaccination 3 digits on one foot were numb. Numbness subsided after several weeks.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Night sweats
Clinical narrative: Hot flashes; night sweats; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 09Jul2021 15:00 (Lot number: EW0176) at the age of 36 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1,SINGLE, Batch/lot number: EW0176 , administration time: 18:30,, Anatomical location: Arm left), administration date: 18Jun2021, when the patient was 36 years old, for COVID-19 immunization. The following information was reported: HOT FLUSH (non-serious) with onset 11Jul2021, outcome "not recovered", described as "Hot flashes"; NIGHT SWEATS (non-serious) with onset 11Jul2021, outcome "not recovered", described as "night sweats". Therapeutic measures were not taken as a result of hot flush, night sweats.  Additional information: No other vaccines received within 4 weeks prior to the covid vaccine, no covid prior vaccination, no covid tested post vaccination. No seriousness criteria provided.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Exposure via breast milk, Illness
Clinical narrative: Reports of children that were dying. I know of one mother who breastfed her child after she was vaccinated herself and her child got very very sick.; Reports of children that were dying. I know of one mother who breastfed her child after she was vaccinated herself and her child got very very sick.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) was exposed to bnt162b2 (BNT162B2), transmammary (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EXPOSURE VIA BREAST MILK (non-serious), ILLNESS (non-serious), outcome "unknown" and all described as "Reports of children that were dying. I know of one mother who breastfed her child after she was vaccinated herself and her child got very very sick.".   Additional Information: They are medical healthcare health care workers exemptions. Women who have been breastfed and their children have died transfer of spike protein to the child. Think how strange this was. Reporter called companies and organizations and every single of them tell them to call your health care provider. Reports of children that were dying. Reporter knew of one mother who breastfed her child after she was vaccinated herself and her child got very very sick. Genocide of the country. That is what is about to happen. Is there a transfer of spike protein in breastmilk to the infant who was not vaccinated but the mother was.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101043747 mother case
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Tinnitus
Clinical narrative: Developed ringing in left ear (tinnitus) 5 days after the vaccination date. Has persisted since. Never had this issue prior to vaccination.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 22 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 06Aug2021 11:00 (Lot number: EW0196) at the age of 22 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: TINNITUS (non-serious) with onset 11Aug2021, outcome "not recovered", described as "Developed ringing in left ear (tinnitus) 5 days after the vaccination date. Has persisted since. Never had this issue prior to vaccination.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of tinnitus.  Additional information: The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the wasn't patient diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. Facility type for COVID-19 vaccine administered was Pharmacy or Drug Store.   No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: Headache; It seems to hurt on the site that I got the shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 12Aug2021 12:00 (Lot number: EW0191) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Back pain" (unspecified if ongoing), notes: Verbatim: Back pain; "Neck pain" (unspecified if ongoing), notes: Verbatim: Neck pain. Concomitant medication(s) included: OXYCODONE taken for neck pain, back pain. The following information was reported: HEADACHE (non-serious) with onset 12Aug2021, outcome "unknown", described as "Headache"; VACCINATION SITE PAIN (non-serious) with onset 12Aug2021, outcome "unknown", described as "It seems to hurt on the site that I got the shot". Therapeutic measures were taken as a result of headache.  Additional information: Patient stated, that he took his shot in morning 12 o'clock and experienced real bad headache and was wondered if this was a possible side effect. It was a pretty bad headache, and it seems to hurt on the site that got the shot. Patient stated that he took an Excedrin Migraine, just one. He was taking Oxycodone for Back and neck pain for 10 years. The patient did not receive any other vaccines within four weeks prior to the vaccination.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal
Clinical narrative: I was whether dizzy, nothing real bad but dizzy; fuzzy head and dizzy; I take blood pressure medicine and one water pill (Unspecified Medication), both of these pills make me little dizzy not bad; I was whether dizzy, nothing real bad but dizzy; fuzzy head and dizzy; I take blood pressure medicine and one water pill (Unspecified Medication), both of these pills make me little dizzy not bad; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A  patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 12Aug2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "blood pressure" (unspecified if ongoing), notes: I take blood pressure medicine and one water pill (Unspecified Medication). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st Dose.), for Covid-19 Immunization. The following information was reported: FEELING ABNORMAL (non-serious) with onset 13Aug2021, outcome "unknown", DIZZINESS (non-serious) with onset 13Aug2021, outcome "recovered" and all described as "I was whether dizzy, nothing real bad but dizzy; fuzzy head and dizzy; I take blood pressure medicine and one water pill (Unspecified Medication), both of these pills make me little dizzy not bad".  Additional Information: Consumer queried if the patient  took the 2nd Pfizer shot yesterday at (withheld) today, IT was whether dizzy, nothing real bad but dizzy. But had developed now in last couple of hours, may be in a hour fuzzy head and dizzy and now the patient took blood pressure medicine and one water pill (Unspecified Medication), both of these pills make me little dizzy not bad and the patient won-dered if one needs to  wait more to take the water pill and blood pressure pill or what. All the pa-tient wanted was the answer if the the blood pressure pill or water pill should be taken today, even though Pfizer shot got one dizzy and now the patient is not dizzy anymore. The LOT number was reported: FC3180.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Mammogram
Clinical narrative: extreme fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Jan2021 18:00 (Lot number: EL8982) at the age of 56 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: PROZAC (ongoing); LISINOPRIL (ongoing); LEVOTHYROXINE (ongoing); WELLBUTRIN (ongoing); OMEP [OMEPRAZOLE] (ongoing). The following information was reported: FATIGUE (non-serious) with onset 23Jan2021, outcome "recovered" (2021), described as "extreme fatigue". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of fatigue.  Additional Information: The AE did not require admission to hospital. The patient was fine now  No follow-up attempts are possible. No further information is expected.   .
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: the hair loss started right away, a big and very different amount of hair.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 23Jun2021 (Lot number: EW0186) at the age of 32 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Covid" (unspecified if ongoing), notes: If covid prior vaccination: Yes. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (lot number=EW0186, lot unknown=False, administration date=01Jun2021, dose number=1), administration date: 01Jun2021, when the patient was 33 years old, for Covid-19 immunization. The following information was reported: ALOPECIA (non-serious) with onset 16Jul2021, outcome "not recovered", described as "the hair loss started right away, a big and very different amount of hair.".  Additional information included: The patient did not receive other vaccine in four weeks. The patient was not Covid tested post vaccination. The patient had no known allergies or other medical history.   No follow-up attempts are possible. No further information is expected.
Age: 78.0
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal
Clinical narrative: I got little fuzzy; I got fuzzy head; dizzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 78 year-old patient received bnt162b2 (BNT162B2), administration date 11Aug2021 (Lot number: HC3180) at the age of 78 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Blood pressure" (unspecified if ongoing), notes: my blood pressure medicine and my water pill which I take; "water pill" (unspecified if ongoing), notes: my blood pressure medicine and my water pill which I take. The patient took concomitant medications. Vaccination history included: Bnt162b2 (First Dose), for Covid -19 Immunization. The following information was reported: FEELING ABNORMAL (non-serious) with onset 12Aug2021, outcome "recovered" (12Aug2021), described as "I got little fuzzy; I got fuzzy head"; DIZZINESS (non-serious) with onset 12Aug2021, outcome "recovered" (Aug2021), described as "dizzy".  Additional information: The patient got fuzzy head, it was gone away, but wondering if the patient should take blood pressure medicine or water pill or not because it (Clarification unknown) made the patient kind of fuzzy.  Follow-up attempts are completed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Hyperhidrosis
Clinical narrative: Hot flashes; Sweating daily; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 10Apr2021 07:30 (Lot number: ER8732) at the age of 62 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing); "Menopausal", start date: 2016 (unspecified if ongoing), notes: Pt has been menopausal since 2016 without symptoms. Concomitant medication(s) included: COZAAR; CHLORTHALIDONE; CALCIUM D; MULTIVIT. Vaccination history included: Bnt162b2 (1st Dose:, lot number=EN6204,, administration time=07:30 AM, vaccine location=Left arm), administration date: 20Mar2021, when the patient was 62 years old, for Covid-19 Immunization. The following information was reported: HOT FLUSH (non-serious) with onset Jul2021, outcome "not recovered", described as "Hot flashes"; HYPERHIDROSIS (non-serious) with onset Jul2021, outcome "not recovered", described as "Sweating daily". Therapeutic measures were not taken as a result of hot flush, hyperhidrosis.  Additional information: Seriousness criteria-Results in death/Seriousness criteria-Life threatening/Seriousness criteria-Caused/prolonged hospitalization/Seriousness criteria-Disabling/Incapacitating/Seriousness criteria-Congenital anomaly/birth defect all were reported as no. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Approx 3 months after inj 2 experiencing hot flashes and sweating daily. Ae results in None of the above. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Known allergies was None.  No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: pains in our arms; nauseous; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 64 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Jul2021 (Lot number: EW0117) at the age of 64 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Blood pressure high" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "pains in our arms"; NAUSEA (non-serious) with onset 2021, outcome "unknown", described as "nauseous". Therapeutic measures were not taken as a result of pain in extremity, nausea.  Additional information: Reporter Stated that her height was about 5.5 and he was not sure and weight about 120 so approximately. Reporter Stated that EW it was like 0117 it was very hard to read. Patient had received dose 1, pfizer vaccine and patient got pains in arms and then patient got nauseous next day.  Follow-Up (26Aug2021): Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Soreness at the arm where the injection was; soreness in the arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2), administered in arm, administration date 12Aug2021 (Lot number: EW0165) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Aug2021, outcome "unknown", described as "Soreness at the arm where the injection was"; PAIN IN EXTREMITY (non-serious) with onset Aug2021, outcome "unknown", described as "soreness in the arm".  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Injection site swelling; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE SWELLING (non-serious), outcome "unknown", described as "Injection site swelling".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Pain in extremity, Skin lesion
Clinical narrative: severe blisters and bumps on hand and palms; severe blisters and bumps on hand and palms; painful due to blisters; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202200326906 (Pfizer).  A 22 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06Aug2021 17:00 (Batch/Lot number: unknown) at the age of 22 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (First Dose, Time: 12:00 PM, vaccine_location=Left arm), administration date: 16Jul2021, when the patient was 22 years old, for Covid-19 Immunization. The following information was reported: BLISTER (non-serious), SKIN LESION (non-serious) all with onset 07Aug2021 08:00, outcome "recovered" (14Aug2021) and all described as "severe blisters and bumps on hand and palms"; PAIN IN EXTREMITY (non-serious) with onset 07Aug2021 08:00, outcome "recovered" (Aug2021), described as "painful due to blisters". Therapeutic measures were not taken as a result of blister, skin lesion, pain in extremity.  Additional information: On 07Aug2021, the morning after the second dose of the vaccine, he noticed severe blisters and bumps on hand and palms. Due to the blisters, he was unable to freely flex or use his hands. Attempting to close his fist or move fingers was painful due to the blisters. This was worsened by hot weather. The blisters remained consistent until 11Aug, after which they faded away. As of 14Aug, they have no re-emerged. Patient not had any known allergies and not had any other medical history. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. Patient not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19 and since the vaccination, patient not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Muscle tightness, Pain in extremity, SARS-CoV-2 test
Clinical narrative: Started having horrible pain in top left leg.; I have an injury to my back; My top legs feel tight and hard to walk; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 24Apr2021 (Lot number: EW0161) at the age of 67 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "fibromylia" (unspecified if ongoing); "rheutamoid" (unspecified if ongoing); "neuropathy" (unspecified if ongoing); "back and nerve injury" (unspecified if ongoing); "back and nerve injury" (unspecified if ongoing); "known allergies: macrodation" (unspecified if ongoing). Concomitant medication(s) included: GABAPENTIN; CALCIUM; VITAMIN C [ASCORBIC ACID]; ZINC; VIT D [COLECALCIFEROL]. Past drug history included: Tetracycline, reaction(s): "known allergies: tetracycline". Vaccination history included: Bnt162b2 (1st Dose, vaccine location=Left arm, administration date=27Mar2021,, brand=Pfizer,, lot number=ep0161,), administration date: 27Mar2021, when the patient was 67 years old, for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 30Apr2021, outcome "not recovered", described as "Started having horrible pain in top left leg."; MUSCLE TIGHTNESS (non-serious) with onset 30Apr2021, outcome "not recovered", described as "I have an injury to my back"; GAIT DISTURBANCE (non-serious) with onset 30Apr2021, outcome "not recovered", described as "My top legs feel tight and hard to walk". The events "started having horrible pain in top left leg.", "i have an injury to my back" and "my top legs feel tight and hard to walk" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain in extremity, muscle tightness, gait disturbance.  Additional information: Patient did not received any other vaccine in four weeks. Patient received steroid as a treatment for AE. Patient did not had COVID-19 prior vaccination. Patient tested for COVID-19 post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Diarrhoea, Fatigue, Inappropriate schedule of product administration, Pain
Clinical narrative: Fatigue; body aches; SEVERE low back pain; diarrhea; Inappropriate schedule of vaccine administered; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 46 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Aug2021 16:45 (Lot number: FC3180) at the age of 46 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Allergy: Penicillin" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Lot number: EL3248, Administration time: 10:00 AM,, Dose number: 1,, Vaccine location: Right arm), administration date: 19Jan2021, when the patient was 46 years old, for COVID-19 Immunization. The following information was reported: FATIGUE (non-serious) with onset 20Aug2021 17:30, outcome "recovered" (23Aug2021), described as "Fatigue"; PAIN (non-serious) with onset 20Aug2021 17:30, outcome "recovered" (23Aug2021), described as "body aches"; BACK PAIN (non-serious) with onset 20Aug2021 17:30, outcome "recovered" (23Aug2021), described as "SEVERE low back pain"; DIARRHOEA (non-serious) with onset 20Aug2021 17:30, outcome "recovered" (26Aug2021), described as "diarrhea"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 20Aug2021, outcome "unknown", described as "Inappropriate schedule of vaccine administered". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of fatigue, pain, back pain, diarrhoea.  Additional information: The patient did not receive other vaccine in four weeks and no other medications in two weeks. Other medical history reported as A-, Rh-, healthy. The patient had fatigue and body aches for 3 days with Severe low back pain started 30 minutes after vaccine also had 6 days of diarrhoea. The patient treatment included 4 Ibuprofen every 4 hours and antidiarrheal pills. Patient had no covid prior vaccination. Patient tested for covid post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Fatigue; body aches; SEVERE low back pain; diarrhea; Inappropriate schedule of vaccine administered; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 46 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Aug2021 16:45 (Lot number: FC3180) at the age of 46 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Allergy: Penicillin" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Lot number: EL3248, Administration time: 10:00 AM,, Dose number: 1,, Vaccine location: Right arm), administration date: 19Jan2021, when the patient was 46 years old, for COVID-19 Immunization. The following information was reported: FATIGUE (non-serious) with onset 20Aug2021 17:30, outcome "recovered" (23Aug2021), described as "Fatigue"; PAIN (non-serious) with onset 20Aug2021 17:30, outcome "recovered" (23Aug2021), described as "body aches"; BACK PAIN (non-serious) with onset 20Aug2021 17:30, outcome "recovered" (23Aug2021), described as "SEVERE low back pain"; DIARRHOEA (non-serious) with onset 20Aug2021 17:30, outcome "recovered" (26Aug2021), described as "diarrhea"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 20Aug2021, outcome "unknown", described as "Inappropriate schedule of vaccine administered". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of fatigue, pain, back pain, diarrhoea.  Additional information: The patient did not receive other vaccine in four weeks and no other medications in two weeks. Other medical history reported as A-, Rh-, healthy. The patient had fatigue and body aches for 3 days with Severe low back pain started 30 minutes after vaccine also had 6 days of diarrhoea. The patient treatment included 4 Ibuprofen every 4 hours and antidiarrheal pills. Patient had no covid prior vaccination. Patient tested for covid post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Muscular weakness
Clinical narrative: chills; headache; muscle weakness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 28 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 17Aug2021 14:00 (Lot number: EW0171) at the age of 28 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypothyroidism", start date: Sep2020 (ongoing). Concomitant medication(s) included: SYNTHROID taken for hypothyroidism, start date: Sep2020 (ongoing). Vaccination history included: Bnt162b2 (Time: 14:00, Anatomical site of injection: Left shoulder, Route of administration: Intramuscular, Batch/Lot number: EW0171), administration date: 27Jul2021, when the patient was 28 years old, for COVID-19 immunization. The following information was reported: CHILLS (non-serious) with onset 18Aug2021, outcome "recovered" (19Aug2021), described as "chills"; HEADACHE (non-serious) with onset 18Aug2021, outcome "recovered" (19Aug2021), described as "headache"; MUSCULAR WEAKNESS (non-serious) with onset 18Aug2021, outcome "recovered" (19Aug2021), described as "muscle weakness". Therapeutic measures were taken as a result of chills, headache, muscular weakness. Additional information: Prior Vaccinations (within 4 weeks) were none. Treatment was reported as yes With details: Tylenol.  Follow-up attempts are completed. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Colonoscopy, Oropharyngeal pain, Pain in extremity
Clinical narrative: had a little pain in the arm; throat was a little sore; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02Feb2021 (Lot number: EL9264) at the age of 72 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Blood pressure" (unspecified if ongoing); "Diabetes" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN taken for blood pressure measurement (ongoing); AMLODIPINE taken for blood pressure measurement (ongoing); ATORVASTATIN taken for blood pressure measurement (ongoing); METFORMIN taken for diabetes mellitus (ongoing). The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "had a little pain in the arm"; OROPHARYNGEAL PAIN (non-serious) with onset 2021, outcome "unknown", described as "throat was a little sore". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: She was scared she was going to get Covid-19; she is an older woman. She was on other Products. She had no Prior Vaccinations (within 4 weeks), Reported as none for her AE(s) following prior vaccinations. Relevant Tests was None.  She is calling regarding the Pfizer Covid-19 shot. She had both of her shots all ready. She had them back in Feb2021. She is trying to find out when she should get the booster shot. She did not have any ill effects from the first shot. She just had a little pain in the arm and her throat was a little sore. That was it, everything else was fine. She has been trying to call where she got the shots from to make an appointment for her booster. She is fine, otherwise, she has aches and pains, of course. She is at that age now where she gets aches and pains. She has had that for a while, like when she sits for a long time or has been walking a long time.  She had a colonoscopy that came out very good, that is all. She barely gets sick. Every now and then she gets a cold, but she is not sickly. While reporting side effects from the Pfizer Covid-19 vaccine, caller mentioned she takes losartan for blood pressure and that her blood pressure fluctuates so bad. She has been taking Losartan for a while now for her blood pressure, it fluctuates so bad. It has been over 3 or 4 years. She Has been taking Amlodipine for 3 or 4 years. she has been taking all these damn pills for blood pressure. Atorvastatin has been taking about the same time, 3 or 4 years, maybe a little longer. She has been taking Metformin about 3 years. Treatment for Just her blood pressure and diabetes medication, nothing specifically for these symptoms.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Mammogram
Clinical narrative: Positive lymph nodes left breast; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2) (Lot number: EN6207) as dose 2, single and (Lot number: EN5981) as dose 1, single for covid-19 immunisation. Relevant medical history included: "asthma" (unspecified if ongoing); "hypertension" (unspecified if ongoing); "history of stroke" (unspecified if ongoing); "allergies: sulfa drugs" (unspecified if ongoing); "allergies: ace inhibitors" (unspecified if ongoing). Concomitant medication(s) included: REQUIP; PLACID [ETOPOSIDE]; SINGULAIR; LOSARTIN; LASIX [FUROSEMIDE]; PANTAB. The following information was reported: LYMPHADENOPATHY (non-serious) with onset May2021, outcome "unknown", described as "Positive lymph nodes left breast". The event "positive lymph nodes left breast" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of lymphadenopathy.  Additional Information: Patient did not receive other vaccine in four weeks. Patient had an abnormal mammogram. Prior to vaccination, patient did not experience covid. Post vaccination, patient was not tested for covid.   No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Lung disorder, Pain
Clinical narrative: This is a spontaneous report received from a noncontactable consumer or other non-HCP (patient), for a Pfizer sponsored program (159558). A male patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), on Aug 25, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medication not reported. The patient experienced pain, back pain and lung disorder, with outcome of unknown. Patient stated he experienced some pain in his body: "Due to the situation regarding with my lungs, I have been experiencing some upper back pain." Therapeutic measures were taken as a result of pain/back pain. Additional information: He experienced some upper back pain, so he took one pill of Celebrex (after more than 24 hours he took the COVID-19 shot). No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.